Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: An experimental murine model

Virology Journal

Volumn 2, Issue , 2005, Pages

  Chávez Bueno, Susana ^a   Mejías, Asunción ^a   Gómez, Ana M ^a   Olsen, Kurt D ^a   Ríos, Ana M ^a   Fonseca Aten, Mónica ^a   Ramilo, Octavio ^a   Jafri, Hasan S ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; RANTES; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; HOST; INFLAMMATION; LUNG LAVAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PLETHYSMOGRAPHY; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; VIRUS INFECTION; VIRUS LOAD; AIRWAY OBSTRUCTION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

MURINAE; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

AIRWAY OBSTRUCTION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RNA, VIRAL; VIRAL LOAD;

EID: 24344444478     PISSN: 1743422X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1743-422X-2-46     Document Type: Article

References (44)

1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ: Bronchiolitis-associated hospitalizations among US children, 1980-1996. Jama 1999, 282(15):1440-1446.
2. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ: Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995, 332(3):133-138.
3. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999, 354(9178):541-545.
4. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161(5):1501-1507.
5. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, Kjellman B: Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005, 171(2):137-141.
6. Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, Santosham M, Harrison LH: Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group. J Infect Dis 1999, 180(1):41-49.
7. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O: Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. J Infect Dis 2004, 189(10):1856-1865.
8. Byrd LG, Prince GA: Animal models of respiratory syncytial virus infection. Clin Infect Dis 1997, 25(6):1363-1368.
9. Sacks D, Noben-Trauth N: The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002, 2(11):845-858.
10. Hazlett LD: Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. DNA Cell Biol 2002, 21(5-6):383-390.
11. Ramakrishna C, Ravi V, Desai A, Subbakrishna DK, Shankar SK, Chandramuki A: T helper responses to Japanese encephalitis virus infection are dependent on the route of inoculation and the strain of mouse used. J Gen Virol 2003, 84(Pt 6):1559-1567.
12. Bangham CR, Cannon MJ, Karzon DT, Askonas BA: Cytotoxic T cell response to respiratory syncytial virus in mice. J Virol 1985, 56(1):55-59.
13. Alwan WH, Record FM, Openshaw PJ: Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J Immunol 1993, 150(12):5211-5218.
14. Hancock GE, Tebbey PW, Scheuer CA, Pryharski KS, Heers KM, LaPierre NA: Immune responses to the nonglycosylated ectodomain of respiratory syncytial virus attachment glycoprotein mediate pulmonary eosinophilia in inbred strains of mice with different MHC haplotypes. J Med Virol 2003, 70(2):301-308.
15. Hussell T, Georgiou A, Sparer TE, Matthews S, Pala P, Openshaw PJ: Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection. J Immunol 1998, 161(11):6215-6222.
16. Srikiatkhachorn A, Chang W, Braciale TJ: Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J Virol 1999, 73(8):6590-6597.
17. Garofalo RP, Hintz KH, Hill V, Ogra PL, Welliver RCS: Production of interferon gamma in respiratory syncytial virus infection of humans is not associated with interleukins 12 and 18. J Med Virol 2004, 73(2):289-294.
18. van Benten IJ, van Drunen CM, Koopman LP, KleinJan A, van Middelkoop BC, de Waal L, Osterhaus AD, Neijens HJ, Fokkens WJ: RSV induced bronchiolitis but not upper respiratory tract infection is accompanied by an increased nasal IL-18 response. J Med Virol 2003, 71(2):290-297.
19. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC: Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis 2001, 184(4):393-399.
20. van Schaik SM, Obot N, Enhorning G, Hintz K, Gross K, Hancock GE, Stack AM, Welliver RC: Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J Med Virol 2000, 62(2):257-266.
21. Johnson TR, Hong S, Van Kaer L, Koezuka Y, Graham BS: NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. J Virol 2002, 76(9):4294-4303.
22. Tekkanat KK, Maassab H, Berlin AA, Lincoln PM, Evanoff HL, Kaplan MH, Lukacs NW: Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection. Am J Pathol 2001, 159(2):631-638.
23. Makela MJ, Kanehiro A, Dakhama A, Borish L, Joetham A, Tripp R, Anderson L, Gelfand EW: The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med 2002, 165(6):824-831.
24. Schwarze J, Cieslewicz G, Hamelmann E, Joetham A, Shultz LD, Lamers MC, Gelfand EW: IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection. J Immunol 1999, 162(5):2997-3004.
25. Rutigliano JA, Graham BS: Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 2004, 173(5):3408-3417.
26. Miller AL, Bowlin TL, Lukacs NW: Respiratory syncytial virusinduced chemokine production: linking viral replication to chemokine production in vitro and in vivo. J Infect Dis 2004, 189(8):1419-1430.
27. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF: MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. Cell Immunol 2000, 206(1):1-6.
28. Noah TL, Becker S: Chemokines in nasal secretions of normal adults experimentally infected with respiratory syncytial virus. Clin Immunol 2000, 97(1):43-49.
29. Noah TL, Ivins SS, Murphy P, Kazachkova I, Moats-Staats B, Henderson FW: Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis. Clin Immunol 2002, 104(1):86-95.
30. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ, Ramilo O: Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Infect Dis J 1999, 18(2):115-122.
31. Bitko V, Garmon NE, Cao T, Estrada B, Oakes JE, Lausch RN, Barik S: Activation of cytokines and NF-kappa B in corneal epithelial cells infected by respiratory syncytial virus: potential relevance in ocular inflammation and respiratory infection. BMC Microbiol 2004, 4(1):28.
32. Kelsen SG, Aksoy MO, Yang Y, Shahabuddin S, Litvin J, Safadi F, Rogers TJ: The Chemokine Receptor, CXCR3, and its Splice Variants are Expressed in Human Airway Epithelial Cells. Am J Physiol Lung Cell Mol Physiol 2004.
33. Pringle C R, Shirodaria PV, Cash P, Chiswell DJ, Malloy P: Initiation and maintenance of persistent infection by respiratory syncytial virus. J Virol 1978, 28(1):199-211.
34. Panuska JR, Cirino NM, Midulla F, Despot JE, McFadden ERJ, Huang YT: Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest 1990, 86(1):113-119.
35. Guerrero-Plata A, Ortega E, Gomez B: Persistence of respiratory syncytial virus in macrophages alters phagocytosis and proinflammatory cytokine production. Viral Immunol 2001, 14(1):19-30.
36. Hegele RG, Robinson PJ, Gonzalez S, Hogg JC: Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus. Eur Respir J 1993, 6(9):1324-1331.
37. Hegele RG, Hayashi S, Bramley AM, Hogg JC: Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 1994, 105(6):1848-1854.
38. Streckert HJ, Philippou S, Riedel F: Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies. Arch Virol 1996, 141(3-4):401-410.
39. Valarcher JF, Bourhy H, Lavenu A, Bourges-Abella N, Roth M, Andreoletti O, Ave P, Schelcher F: Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 2001, 291(1):55-67.
40. Schwarze J, O'Donnell DR, Rohwedder A, Openshaw PJ: Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 2004, 169(7):801-805.
41. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003, 58(1):37-42.
42. Cubie HA, Duncan LA, Marshall LA, Smith NM: Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr Pathol Lab Med 1997, 17(6):927-938.
43. Mejias A, Chavez-Bueno S, Rios AM, Saavedra-Lozano J, Fonseca Aten M, Hatfield J, Kapur P, Gomez AM, Jafri HS, Ramilo O: Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model. Antimicrob Agents Chemother 2004, 48(5):1811-1822.
44. van Woensel JB, Lutter R, Biezeveld MH, Dekker T, Nijhuis M, van Aalderen WM, Kuijpers TW: Effect of dexamethasone on tracheal viral load and interleukin-8 tracheal concentration in children with respiratory syncytial virus infection. Pediatr Infect Dis J 2003, 22(8):721-726.